# Xydalba Utilization Registry in Germany

> **NCT03696901** · — · TERMINATED · sponsor: **Correvio International Sarl** · enrollment: 16 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** Xydalba

## Key facts

- **NCT ID:** NCT03696901
- **Lead sponsor:** Correvio International Sarl
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-21
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-04-07
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Terminated
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696901, "Xydalba Utilization Registry in Germany". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03696901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*